Jeena Sikho Lifecare Submits Revised Investor Presentation for Q4FY26 & FY26 Results
Jeena Sikho Lifecare Limited submitted a revised investor presentation on June 1, 2026, for Q4FY26 and FY26 results. FY26 revenue was ₹80,135 lakhs, with EBITDA at ₹34,963 lakhs. Q4FY26 revenue increased 55% YoY to ₹21,555 lakhs, and PAT rose 79% YoY to ₹4,535 lakhs. A final dividend of ₹4.50 per share is proposed.
This is an update to a previously submitted investor presentation. The core financial information is not new, and the revision is for clarification purposes, thus having a minimal direct impact on immediate market perception.
The announcement is a routine submission of a revised investor presentation. While it contains positive financial results, the primary purpose is disclosure and updates, not a new strategic announcement or significant event.
Jeena Sikho Lifecare Limited (JSLL) has submitted a revised investor presentation on June 1, 2026, superseding the version shared on May 31, 2026. This revision incorporates updates, modifications, and additional clarifications to the previously submitted presentation concerning the company's financial performance for the fourth quarter and the full financial year ended March 31, 2026.
The revised presentation is being utilized during a meeting with investors scheduled for Tuesday, June 02, 2026. It is also available on the company's official website, www.jeenasikho.com.
The presentation details the company's financial highlights for FY22 through FY26, including Revenue from Operations, Gross Profit, EBITDA, and Profit After Taxes. Notably, for FY26, Revenue from Operations reached ₹80,135 lakhs, with EBITDA at ₹34,963 lakhs and Profit After Taxes at ₹22,218 lakhs. Quarterly performance for Q4FY26 shows Revenue from Operations at ₹21,555 lakhs, a 55% year-on-year increase from Q4FY25, and Profit After Taxes at ₹4,535 lakhs, up 79% year-on-year. The company also recommended a final dividend of ₹4.50 per equity share for FY25-26.
What to do with a filing like this
Jeena Sikho Lifecare Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jeena Sikho Lifecare Limited. Read the original for the full detail.